Radiotherapy of brain metastases from lung cancer: evidences and areas of research

References

[1] Gaspar LE,Hdeib A,Lasker GF.Congress of neurologic surgeons systematic review and evidence-based guideline hihges on the role of whole brain radiation therapy in adults with newly diagnosed metastatic brain tumors..Neurosurg2019;84:e159-62

[2] Kocher M,Abacioglu U,Fauchon F.Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study..J Clin Oncol2011;29:134-41 PMCID:PMC3058272

[3] Brown PD,Ballman KV,Cerhan JH.Effects of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial..JAMA2016;316:401-9 PMCID:PMC5313044

[4] Brown PD,Cerhan JH,Carrero XW.Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial..Lancet Oncol2017;18:1049-60 PMCID:PMC5568757

[5] Komosinska K,Niwinska A,Wierzchowski M.Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status..Acta Oncol2010;49:382-8

[6] Mulvenna P,Barton R,Wilson P.Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial..Lancet2016;388:2004-14 PMCID:PMC5082599

[7] Gaspar L,Rotman M,Phillips T.Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials..Int J Radiat Oncol Biol Phys1997;37:745-51

[8] Kepka L,Bujko K.Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis..Acta Oncol2005;44:389-98

[9] Sperduto PW,Roberge D,Shanley R.Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases..J Clin Oncol2012;30:419-25 PMCID:PMC3269967

[10] Sperduto PW,Beal K,Brown PD.The effect of gene alterations and tyrosine kinase inhibition on survival and cause of death in patients with adenocarcinoma of the lung and brain metastases..Int J Radiat Oncol Biol Phys2016;96:406-13 PMCID:PMC5575932

[11] Brown PD,Pugh S,Wefel JS.Hippocampal avoidance during whole-brain radiotherapy for patients with brain metastases: phase III trial NRG Oncology CC001..J Clin Oncol2020;38:1019-29 PMCID:PMC7106984

[12] Kirakli EK.Radiotherapy of brain metastases from non-small cell lung cancer..J Cancer Metastasis Treat2019;5:10

[13] Gutiérrez-Valencia E,Balderrama-Ibarra R,Rios-Martínez A.Diagnosis and management of brain metastases: an updated review from a radiation oncology perspective..J Cancer Metastasis Treat2019;5:54

[14] Dumane VA,Sheu RD,Gupta V.Training and evaluation of a knowledge-based model for automated treatment planning of multiple brain metastases..J Cancer Metastasis Treat2019;5:42

[15] Mudra S,Tripathi P,Kloecker G.Stereotactic radiosurgery in the era of novel systemic therapy for lung cancer brain metastases..J Cancer Metastasis Treat2019;5:27

[16] Kepka L.Radiotherapy of brain metastases from small-cell lung cancer: standards and controversies..J Cancer Metastasis Treat2019;5:53

[17] Wartena R,Belderbos J.Are memantine, methylphenidate and donepezil effective in sparing cognitive functioning after brain irradiation?.J Cancer Metastasis Treat2018;4:59